Fig 2 shows the percentage of patients with treated diabetes with a prescription for insulin, sulphonylureas, alpha-glucosidase inhibitors, metformin, meglitinides, thiazolidinediones and DPP-4 inhibitors from 2002 until 2013. This evidence concerns the gene INS and diabetes mellitus.